(Q40838932)

English

Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study (English)

1 reference

Europe PubMed Central

24 September 2017

4

object named as

R J Glynn

1 reference

Europe PubMed Central

24 September 2017

author name string

E Patorno

1

1 reference

Europe PubMed Central

24 September 2017

B M Everett

2

1 reference

Europe PubMed Central

24 September 2017

A B Goldfine

3

1 reference

Europe PubMed Central

24 September 2017

J Liu

5

1 reference

Europe PubMed Central

24 September 2017

C Gopalakrishnan

6

1 reference

Europe PubMed Central

24 September 2017

S C Kim

7

1 reference

Europe PubMed Central

24 September 2017

publication date

22 March 2016

1 reference

Europe PubMed Central

24 September 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

24 September 2017

18

1 reference

Europe PubMed Central

24 September 2017

8

1 reference

Europe PubMed Central

24 September 2017

755-765

1 reference

Europe PubMed Central

24 September 2017

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Glucagon-like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

The effect of glucagon-like peptide 1 on cardiovascular risk

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Glucagon-like peptide-1 receptor agonists for diabetes mellitus: a role in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Effect of GLP-1 mimetics on blood pressure and relationship to weight loss and glycemia lowering: results of a systematic meta-analysis and meta-regression.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Glucagon-like peptide-1 receptor agonists and cardiovascular events: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Validating administrative data in stroke research

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

A systematic review of validated methods for identifying heart failure using administrative data

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Estimating causal effects from large data sets using propensity scores

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

One-to-many propensity score matching in cohort studies.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12665

21 January 2018

Identifiers

10.1111/DOM.12665

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40838932&oldid=1908489961"